Home
ANVS
ANVS News

Latest Annovis Bio Inc. (ANVS) News on July 27, 2024

Viking (VKTX) Q2 Earnings Beat, Stock Up on Pipeline Updates

Zacks

a day ago

Viking (VKTX) Q2 Earnings Beat, Stock Up on Pipeline Updates

Annovis Bio Secures U.S. Patent for Treatment of Acute Traumatic Brain Injury with Buntanetap

GlobeNewswire

3 days ago

Annovis Bio Secures U.S. Patent for Treatment of Acute Traumatic Brain Injury with Buntanetap

MT Newswires

10 days ago

Annovis Bio Says US FDA Approved Use of Neurodegeneration Drug Buntanetap in Crystalline Form

Annovis Bio Receives FDA Approval to Transition to New Crystal Form of Buntanetap

GlobeNewswire

11 days ago

Annovis Bio Receives FDA Approval to Transition to New Crystal Form of Buntanetap

Pacira (PCRX) Rises on Proposed Exparel Reimbursement Plan

Zacks

14 days ago

Pacira (PCRX) Rises on Proposed Exparel Reimbursement Plan

Brookdale Senior (BKD) Q2 Occupancy Jumps, Growth Trend Persists

Zacks

16 days ago

Brookdale Senior (BKD) Q2 Occupancy Jumps, Growth Trend Persists

Adicet (ACET) Up as Kidney Cancer Drug Gets FDA's Fast Track Tag

Zacks

17 days ago

Adicet (ACET) Up as Kidney Cancer Drug Gets FDA's Fast Track Tag

Annovis Bio Welcomes Four New Executives to Strengthen Leadership Team

GlobeNewswire

18 days ago

Annovis Bio Welcomes Four New Executives to Strengthen Leadership Team

Annovis stock swells after Phase III Parkinson’s subgroup success

Clinical Trials Arena

23 days ago

Annovis stock swells after Phase III Parkinson’s subgroup success

Annovis Bio shares dip on phase III Parkinson's trial data

Yahoo Finance Video

23 days ago

Annovis Bio shares dip on phase III Parkinson's trial data

Annovis (ANVS) Up as Its Lead Candidate Meets Goals in PD Study

Zacks

23 days ago

Annovis (ANVS) Up as Its Lead Candidate Meets Goals in PD Study

MT Newswires

24 days ago

Annovis Shares Rise After Study Shows Effectiveness of Parkinson's Treatment Candidate

Annovis Bio Announces New Data from Phase III Parkinson’s Study Highlighting Improvements in Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and Cognition after Treatment with Buntanetap

GlobeNewswire

25 days ago

Annovis Bio Announces New Data from Phase III Parkinson’s Study Highlighting Improvements in Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and Cognition after Treatment with Buntanetap

Merck's (MRK) New Pneumococcal Jab Capvaxive Gets CDC Panel Vote

Zacks

a month ago

Merck's (MRK) New Pneumococcal Jab Capvaxive Gets CDC Panel Vote

CASI Pharmaceuticals (CASI) Up on Buyout Offer for China Business

Zacks

a month ago

CASI Pharmaceuticals (CASI) Up on Buyout Offer for China Business

Annovis Bio Files Provisional Patent for New Manufacturing Process of Crystalline Form of Buntanetap

GlobeNewswire

a month ago

Annovis Bio Files Provisional Patent for New Manufacturing Process of Crystalline Form of Buntanetap

ImmunityBio (IBRX) Gains 17% in the Past Week: Here's Why

Zacks

a month ago

ImmunityBio (IBRX) Gains 17% in the Past Week: Here's Why

Annovis Bio Files Patent for New Composition of Matter for Buntanetap

GlobeNewswire

a month ago

Annovis Bio Files Patent for New Composition of Matter for Buntanetap

Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Discuss Parkinson’s Disease Data

GlobeNewswire

a month ago

Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Discuss Parkinson’s Disease Data

Annovis Bio Highlights New Alzheimer’s Data at the Alzheimer’s Association International Conference® 2024

GlobeNewswire

a month ago

Annovis Bio Highlights New Alzheimer’s Data at the Alzheimer’s Association International Conference® 2024

Annovis Bio’s Buntanetap Found Safe and Effective in High-Risk Alzheimer's Patients

GlobeNewswire

2 months ago

Annovis Bio’s Buntanetap Found Safe and Effective in High-Risk Alzheimer's Patients

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities

PR Newswire

2 months ago

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities

Business Wire

2 months ago

Form 8.3 - International Distribution Services plc

Business Wire

2 months ago

Form 8.3 - Darktrace plc

US Supreme Court rejects Kroger challenge to Grubhub trademark win

Reuters

2 months ago

US Supreme Court rejects Kroger challenge to Grubhub trademark win

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect

Investor's Business Daily

2 months ago

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina

Business Wire

2 months ago

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina

GlobeNewswire

2 months ago

Middlefield Canadian Income PCC: Net Asset Value(s)

Business Wire

2 months ago

Form 8.3 - International Paper Company

Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast

GlobeNewswire

2 months ago

Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast

Wall Street Analysts Think Annovis Bio (ANVS) Could Surge 359.53%: Read This Before Placing a Bet

Zacks

2 months ago

Wall Street Analysts Think Annovis Bio (ANVS) Could Surge 359.53%: Read This Before Placing a Bet

Verastem (VSTM) Up on Upbeat Early Pancreatic Cancer Study Data

Zacks

2 months ago

Verastem (VSTM) Up on Upbeat Early Pancreatic Cancer Study Data

Bicycle Therapeutics (BCYC) Up as PIPE Funding Set to Make $555M

Zacks

2 months ago

Bicycle Therapeutics (BCYC) Up as PIPE Funding Set to Make $555M

Deciphera's (DCPH) Shares Surge 74.3% in a Month: Here's Why

Zacks

2 months ago

Deciphera's (DCPH) Shares Surge 74.3% in a Month: Here's Why

Annovis Announces New Publication in a Peer-Reviewed Journal

GlobeNewswire

2 months ago

Annovis Announces New Publication in a Peer-Reviewed Journal

Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC

Zacks

2 months ago

Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC

Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus

Zacks

2 months ago

Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus

Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results

GlobeNewswire

2 months ago

Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results

Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated

Zacks

3 months ago

Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated

Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus

Zacks

3 months ago

Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus

Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues

Zacks

3 months ago

Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues

Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease

GlobeNewswire

3 months ago

Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease

Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss

Zacks

3 months ago

Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss

Intra-Cellular (ITCI) Q1 Earnings and Sales Beat Estimates

Zacks

3 months ago

Intra-Cellular (ITCI) Q1 Earnings and Sales Beat Estimates

Pacira (PCRX) Q1 Earnings Miss, Exparel Sales Drive Revenues

Zacks

3 months ago

Pacira (PCRX) Q1 Earnings Miss, Exparel Sales Drive Revenues

Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat

Zacks

3 months ago

Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat

Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders

GlobeNewswire

3 months ago

Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders

Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises

Zacks

3 months ago

Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises

Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates

Zacks

3 months ago

Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates

Novo Nordisk (NVO) Q1 Earnings Beat, GLP-1 Drugs Boost Sales

Zacks

3 months ago

Novo Nordisk (NVO) Q1 Earnings Beat, GLP-1 Drugs Boost Sales

MT Newswires

3 months ago

Canaccord Genuity Cuts Price Target on Annovis Bio to $26 From $36, Maintains Buy Rating

MT Newswires

3 months ago

Top Midday Decliners

MT Newswires

3 months ago

Annovis Bio Shares Tumble After Drug Candidate Buntanetap for Alzheimer's Misses Efficacy Endpoint in Phase 2/3 Study

Reuters

3 months ago

UPDATE 2-Annovis tumbles as Alzheimer's treatment misses in mid-stage study

Reuters

3 months ago

CORRECTED- Annovis Bio fails to meet main goal of mid-stage Alzheimer's treatment trial

Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease

GlobeNewswire

3 months ago

Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease

Wall Street Analysts Believe Annovis Bio (ANVS) Could Rally 197.98%: Here's is How to Trade

Zacks

3 months ago

Wall Street Analysts Believe Annovis Bio (ANVS) Could Rally 197.98%: Here's is How to Trade

Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies

Zacks

3 months ago

Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies

Vertex (VRTX) Begins Rolling NDA Filing for Acute Pain Drug

Zacks

3 months ago

Vertex (VRTX) Begins Rolling NDA Filing for Acute Pain Drug

Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study

Zacks

3 months ago

Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study

DiaMedica (DMAC) Up as Stroke Study Dosing Begins Post Relaunch

Zacks

3 months ago

DiaMedica (DMAC) Up as Stroke Study Dosing Begins Post Relaunch

Intra-Cellular (ITCI) Up as Depression Drug Meets Study Goals

Zacks

3 months ago

Intra-Cellular (ITCI) Up as Depression Drug Meets Study Goals

Ultragenyx (RARE) Meets Efficacy Goal in Neuro Disease Study

Zacks

3 months ago

Ultragenyx (RARE) Meets Efficacy Goal in Neuro Disease Study

Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why

Zacks

3 months ago

Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why

RallyBio (RLYB) Partners With J&J & Gets $6.6M Funding, Stock Up

Zacks

3 months ago

RallyBio (RLYB) Partners With J&J & Gets $6.6M Funding, Stock Up

Candel (CADL) Up as Pancreatic Cancer Drug Gets Orphan Drug Tag

Zacks

3 months ago

Candel (CADL) Up as Pancreatic Cancer Drug Gets Orphan Drug Tag

Eyenovia (EYEN) Down 18% on Disappointing Corporate Update

Zacks

4 months ago

Eyenovia (EYEN) Down 18% on Disappointing Corporate Update

Ocugen (OCGN) Up as DSMB Allows Cohort 2 Dosing in GA Study

Zacks

4 months ago

Ocugen (OCGN) Up as DSMB Allows Cohort 2 Dosing in GA Study

Wall Street Analysts See a 218.92% Upside in Annovis Bio (ANVS): Can the Stock Really Move This High?

Zacks

4 months ago

Wall Street Analysts See a 218.92% Upside in Annovis Bio (ANVS): Can the Stock Really Move This High?

Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

4 months ago

Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results

Annovis Announces Publication That Supports Understanding of Buntanetap’s Mechanism of Action in Humans

GlobeNewswire

4 months ago

Annovis Announces Publication That Supports Understanding of Buntanetap’s Mechanism of Action in Humans

Wall Street Analysts Think Annovis Bio (ANVS) Could Surge 211.71%: Read This Before Placing a Bet

Zacks

4 months ago

Wall Street Analysts Think Annovis Bio (ANVS) Could Surge 211.71%: Read This Before Placing a Bet

Annovis Bio Provides Data Announcement Update for the Phase II/III Study of Buntanetap in Alzheimer’s Disease

GlobeNewswire

4 months ago

Annovis Bio Provides Data Announcement Update for the Phase II/III Study of Buntanetap in Alzheimer’s Disease

Are Options Traders Betting on a Big Move in Annovis Bio (ANVS) Stock?

Zacks

4 months ago

Are Options Traders Betting on a Big Move in Annovis Bio (ANVS) Stock?

Sell Signal: 3 Stocks to Unload Before the Bubble Bursts

InvestorPlace

5 months ago

Sell Signal: 3 Stocks to Unload Before the Bubble Bursts

Annovis Bio Announces Participation in Forum Discussion at AD/PD™ 2024

GlobeNewswire

5 months ago

Annovis Bio Announces Participation in Forum Discussion at AD/PD™ 2024

12 $10 Stocks That Will Triple

Insider Monkey

5 months ago

12 $10 Stocks That Will Triple

Annovis Bio Announces Last Patient Last Visit in the Phase II/III Study of Buntanetap in Alzheimer’s Disease

GlobeNewswire

5 months ago

Annovis Bio Announces Last Patient Last Visit in the Phase II/III Study of Buntanetap in Alzheimer’s Disease

3 Growth Stocks to Sell in February Before They Bottom

InvestorPlace

5 months ago

3 Growth Stocks to Sell in February Before They Bottom

Perfect Corp. Expands AI Skin Simulation Technology, Helping Consumers Visualize Skin Improvements in Seconds

Business Wire

6 months ago

Perfect Corp. Expands AI Skin Simulation Technology, Helping Consumers Visualize Skin Improvements in Seconds

Annovis Bio Announces the Filing of New Patent Application for Treatment of Mental Illnesses Expanding the Company’s Portfolio

GlobeNewswire

6 months ago

Annovis Bio Announces the Filing of New Patent Application for Treatment of Mental Illnesses Expanding the Company’s Portfolio

Hanover Bancorp's (NASDAQ:HNVR) Dividend Will Be $0.10

Simply Wall St.

6 months ago

Hanover Bancorp's (NASDAQ:HNVR) Dividend Will Be $0.10

With 30% stake, 1stdibs.Com, Inc. (NASDAQ:DIBS) seems to have captured institutional investors' interest

Simply Wall St.

6 months ago

With 30% stake, 1stdibs.Com, Inc. (NASDAQ:DIBS) seems to have captured institutional investors' interest

Oceaneering International, Inc. (OII) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

6 months ago

Oceaneering International, Inc. (OII) Is a Trending Stock: Facts to Know Before Betting on It

Why Investors Need to Take Advantage of These 2 Oils-Energy Stocks Now

Zacks

6 months ago

Why Investors Need to Take Advantage of These 2 Oils-Energy Stocks Now

OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape

GlobeNewswire

6 months ago

OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux

GlobeNewswire

6 months ago

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux

USA TODAY NETWORK Ventures Announces 2024 Legends Party With NFL Alumni Legends

Business Wire

6 months ago

USA TODAY NETWORK Ventures Announces 2024 Legends Party With NFL Alumni Legends

Annovis Bio Refines Timeline for Parkinson’s Phase III Study Data Announcement

GlobeNewswire

6 months ago

Annovis Bio Refines Timeline for Parkinson’s Phase III Study Data Announcement

Insiders own 28% of Annovis Bio, Inc. (NYSE:ANVS) shares but individual investors control 57% of the company

Simply Wall St.

6 months ago

Insiders own 28% of Annovis Bio, Inc. (NYSE:ANVS) shares but individual investors control 57% of the company

Thomson Reuters StreetEvents

6 months ago

Q4 2023 Five Point Holdings LLC Earnings Call

ContextLogic Inc.'s (NASDAQ:WISH) top owners are individual investors with 45% stake, while 44% is held by institutions

Simply Wall St.

6 months ago

ContextLogic Inc.'s (NASDAQ:WISH) top owners are individual investors with 45% stake, while 44% is held by institutions

United States Food & Drug Administration (FDA) Grants Mesoblast Rare Pediatric Disease Designation for Revascor® (Rexlemestrocel-L) in Children With Congenital Heart Disease

GlobeNewswire

6 months ago

United States Food & Drug Administration (FDA) Grants Mesoblast Rare Pediatric Disease Designation for Revascor® (Rexlemestrocel-L) in Children With Congenital Heart Disease

Five Point Holdings LLC Reports Robust Earnings Amid Economic Challenges

GuruFocus.com

6 months ago

Five Point Holdings LLC Reports Robust Earnings Amid Economic Challenges

Associated Press Finance

6 months ago

Five Point: Q4 Earnings Snapshot

Five Point Holdings, LLC Reports Fourth Quarter and Year-End 2023 Results

Business Wire

6 months ago

Five Point Holdings, LLC Reports Fourth Quarter and Year-End 2023 Results

Analysts Estimate Citizens & Northern (CZNC) to Report a Decline in Earnings: What to Look Out for

Zacks

6 months ago

Analysts Estimate Citizens & Northern (CZNC) to Report a Decline in Earnings: What to Look Out for

Perspective Therapeutics Announces Proposed Public Offering

GlobeNewswire

6 months ago

Perspective Therapeutics Announces Proposed Public Offering

Month-end portfolio data now available for Federated Hermes Premier Municipal Income Fund

PR Newswire

6 months ago

Month-end portfolio data now available for Federated Hermes Premier Municipal Income Fund

RG6501 (OpRegen®) Phase 1/2a Results Will Be Featured at 2024 Angiogenesis Exudation and Degeneration Meeting in Presentation by Allen Ho, MD, FACS, FASRS

Business Wire

6 months ago

RG6501 (OpRegen®) Phase 1/2a Results Will Be Featured at 2024 Angiogenesis Exudation and Degeneration Meeting in Presentation by Allen Ho, MD, FACS, FASRS

Share on Social Networks: